---
title: "Morepen Laboratories Ltd (MOREPENLAB) — Share Price, Financials & Analysis"
symbol: "MOREPENLAB"
company: "Morepen Laboratories Ltd"
canonical: "https://tapetide.com/stocks/MOREPENLAB"
isin: "INE083A01026"
nse_symbol: "MOREPENLAB"
bse_code: "500288"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 6142.56
generated_at: "2026-09-13T19:57:05.343Z"
---

# Morepen Laboratories Ltd (MOREPENLAB)

Canonical page: https://tapetide.com/stocks/MOREPENLAB

## Company

- **NSE Symbol:** MOREPENLAB
- **BSE Code:** 500288
- **ISIN:** INE083A01026
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 1999-11-24
- **CEO:** Mr. Sushil Suri B.Sc., F.C.A.
- **Employees:** 1814
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** morepen.com

## About

Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products.[1]

## Latest Price

- **Price:** ₹115.78
- **Change:** +0.5 (+0.43%)
- **Open:** ₹114.5
- **Day High:** ₹117.7
- **Day Low:** ₹111.01
- **Previous Close:** ₹115.28
- **Volume:** 15303804
- **As Of:** 2026-09-11T10:29:57+00:00

## Key Fundamentals

Observed at 2026-09-11T04:54:08.449149Z.

- **Market Cap:** ₹6142.56 Cr
- **Classification:** Microcap
- **P/E (reported):** 44.8
- **P/E (TTM):** 45.05
- **EPS (TTM):** ₹2.57
- **EPS (reported):** ₹2.15
- **Book Value:** ₹22.75
- **Price to Book:** 5.06
- **Dividend Yield:** 0.17%
- **ROE:** 7.67%
- **ROCE:** 9.43%
- **Debt to Equity:** 0.17
- **Revenue (yearly):** ₹1827 Cr
- **Net Income:** ₹95.6 Cr
- **EBITDA:** ₹146.9 Cr
- **52-Week High:** ₹122.55
- **52-Week Low:** ₹33.05
- **RSI (14):** 71.82

## Tapetide Score

- **Score:** 43 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 22.3 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 49.71 | 9% |
| growth | 31.89 | 9% |
| momentum | 98.9 | 12% |
| ownership | 47.82 | 24% |
| quality | 25.79 | 22% |
| valuation | 43.91 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Stock is trading at 5.09 times its book value
- The company has delivered a poor sales growth of 8.73% over past five years.
- Company has a low return on equity of 9.26% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 1.81% | -55.51% | 154.18% |
| ebitda margin growth | 166.57% | -23.57% | -20.63% | -14.83% |
| net income growth | 258.6% | -18.98% | 18% | -8% |
| revenue growth | 16.65% | -0.16% | 8% | 9% |
| roce | 192.12% | -26.33% | -39.59% | 12.92% |
| roe | 258.92% | -22.84% | 9.67% | -56.4% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 422 | 445 | 423 | 455 | 438 | 453 | 466 | 425 | 412 | 484 | 485 | 570 |
| Expenses | 388 | 394 | 375 | 404 | 394 | 417 | 424 | 401 | 381 | 438 | 460 | 488 |
| Operating Profit | 34 | 51 | 48 | 52 | 44 | 36 | 42 | 24 | 31 | 46 | 24 | 83 |
| OPM % | 8 | 11 | 11 | 11 | 10 | 8 | 9 | 6 | 7 | 10 | 5 | 14 |
| Other Income | 3 | 4 | 4 | 3 | 5 | 5 | 5 | 4 | 30 | 4 | 8 | 5 |
| Interest | 0 | 2 | 1 | 1 | 1 | 1 | 5 | 4 | 4 | 4 | 4 | 5 |
| Depreciation | 8 | 8 | 10 | 6 | 2 | 5 | 16 | 9 | 11 | 10 | 6 | 8 |
| Profit before tax | 29 | 44 | 42 | 48 | 46 | 35 | 26 | 16 | 46 | 35 | 23 | 75 |
| Tax % | 26 | 27 | 32 | 25 | 24 | 24 | 21 | 26 | 10 | 22 | 33 | 24 |
| Net Profit | 21 | 32 | 29 | 36 | 35 | 27 | 20 | 11 | 41 | 28 | 16 | 56 |
| EPS in Rs | 0.42 | 0.63 | 0.55 | 0.71 | 0.64 | 0.49 | 0.37 | 0.2 | 0.75 | 0.5 | 0.29 | 1.03 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 607 | 769 | 853 | 1188 | 1547 | 1418 | 1690 | 1812 | 1806 | 1951 |
| Expenses | 542 | 701 | 785 | 1070 | 1410 | 1338 | 1532 | 1638 | 1680 | 1767 |
| Operating Profit | 65 | 68 | 69 | 119 | 137 | 80 | 159 | 174 | 126 | 184 |
| OPM % | 11 | 9 | 8 | 10 | 9 | 6 | 9 | 10 | 7 | 9 |
| Other Income | 4 | 4 | 9 | 12 | 10 | 6 | 14 | 18 | 47 | 48 |
| Interest | 4 | 2 | 2 | 2 | -7 | 2 | 4 | 8 | 16 | 17 |
| Depreciation | 34 | 40 | 37 | 30 | 28 | 28 | 33 | 29 | 36 | 36 |
| Profit before tax | 30 | 29 | 39 | 99 | 127 | 56 | 135 | 155 | 120 | 179 |
| Tax % | 0 | 1 | 14 | 1 | 20 | 31 | 29 | 24 | 20 | — |
| Net Profit | 30 | 29 | 34 | 97 | 102 | 39 | 97 | 118 | 96 | 141 |
| EPS in Rs | 0.66 | 0.64 | 0.75 | 2.16 | 2.13 | 0.76 | 1.88 | 2.15 | 1.73 | 2.57 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 12 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 90 | 90 | 90 | 90 | 90 | 96 | 102 | 102 | 110 | 110 |
| Reserves | 106 | 136 | 163 | 194 | 335 | 483 | 651 | 745 | 1047 | 1137 |
| Borrowings | 169 | 134 | 132 | 133 | 17 | 19 | 25 | 29 | 105 | 208 |
| Other Liabilities | 173 | 226 | 230 | 246 | 416 | 473 | 332 | 417 | 517 | 482 |
| Total Liabilities | 538 | 586 | 615 | 663 | 858 | 1070 | 1110 | 1293 | 1778 | 1936 |
| Fixed Assets | 272 | 264 | 236 | 216 | 225 | 252 | 267 | 307 | 489 | 513 |
| CWIP | 0 | 0 | 0 | 0 | 2 | 14 | 17 | 24 | 28 | 22 |
| Investments | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 85 | 124 |
| Other Assets | 266 | 321 | 379 | 446 | 631 | 804 | 827 | 960 | 1176 | 1277 |
| Total Assets | 538 | 586 | 615 | 663 | 858 | 1070 | 1110 | 1293 | 1778 | 1936 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 41 | 63 | 17 | 11 | 51 | -60 | -91 | 73 | 32 | 33 |
| Cash from Investing Activity | -14 | -27 | -13 | -12 | -70 | -32 | -47 | -83 | -322 | -126 |
| Cash from Financing Activity | -24 | -38 | 0 | 5 | 47 | 66 | 144 | 5 | 300 | 97 |
| Net Cash Flow | 3 | -1 | 4 | 4 | 28 | -26 | 6 | -5 | 10 | 4 |
| Free Cash Flow | 31 | 37 | 6 | -6 | 10 | -127 | -137 | -8 | -182 | -127 |
| CFO/OP | 66 | 98 | 26 | 25 | 44 | -26 | -94 | 70 | 40 | 46 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 57 | 73 | 64 | 59 | 56 | 59 | 68 | 70 | 65 | 67 |
| Inventory Days | 65 | 76 | 69 | 91 | 82 | 96 | 87 | 85 | 94 | 88 |
| Days Payable | 125 | 173 | 124 | 113 | 98 | 90 | 87 | 101 | 114 | 103 |
| Cash Conversion Cycle | -3 | -24 | 9 | 37 | 40 | 65 | 69 | 54 | 45 | 53 |
| Working Capital Days | -86 | -62 | -34 | -8 | 17 | 55 | 98 | 94 | 107 | 118 |
| ROCE % | 9 | 9 | 8 | 10 | 23 | 23 | 8 | 17 | 15 | 8 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 38.22% | 38.22% | 38.22% | 38.22% | 35.65% | 35.65% | 35.65% | 35.65% | 35.65% | 35.65% | 35.65% | 35.65% |
| FIIs | 1.29% | 2.11% | 1.85% | 1.67% | 2.08% | 2.22% | 1.94% | 1.72% | 1.62% | 1.62% | 1.59% | 1.46% |
| DIIs | 2.28% | 2% | 2.15% | 2.15% | 1.7% | 1.64% | 1.67% | 1.51% | 1.5% | 1.25% | 1.25% | 1.28% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 45.56% | 44.44% | 45.03% | 45.22% | 48.16% | 48.35% | 48.76% | 49.35% | 49.96% | 50.28% | 50.03% | 49.75% |
| Others | 12.64% | 13.22% | 12.74% | 12.74% | 12.41% | 12.12% | 11.96% | 11.76% | 11.26% | 11.18% | 11.47% | 11.84% |
| No. of Shareholders | 304001 | 304289 | 336019 | 348766 | 430929 | 448361 | 468860 | 461180 | 461853 | 453137 | 447286 | 434912 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 4 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 113.76 | Buy |
| EMA (10) | 112.38 | Buy |
| SMA (20) | 104.29 | Buy |
| EMA (20) | 104.2 | Buy |
| SMA (50) | 80.21 | Buy |
| EMA (50) | 86.13 | Buy |
| SMA (100) | 63.5 | Buy |
| EMA (100) | 71.27 | Buy |
| SMA (200) | 51.61 | Buy |
| EMA (200) | 60.65 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 72.16 | Sell |
| MACD (12,26,9) | 11.12 | Sell |
| Stochastic (14,3,3) | 77.73 | Neutral |
| ADX (14) | 63.17 | Buy |
| Williams %R (14) | -22.68 | Neutral |
| ATR (14) | 6.31 | High Volatility |
| ROC (12) | 19.39 | Buy |
| Stoch RSI (14) | 3.52 | Buy |
| UO (7,14,28) | 54.78 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Announcement Under Regulation 30 Of The SEBI (LODR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afee3789-746d-4259-9838-26d257e2145d.pdf) |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf80fa95-bf87-4a63-bad6-0328eaadb8fa.pdf) |
| 2026-09-02 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee81e47d-cbe5-48fc-aa14-ef166be4951e.pdf) |
| 2026-09-02 | [Notice Of 41St Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a53d7ee-7112-46e2-9784-3c829be0e100.pdf) |
| 2026-09-02 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60eeb0da-5b3d-4c1b-9b57-197c80d2ae50.pdf) |
| 2026-09-02 | [Letter To The Members (No E-Mail Id Registered) Comprising Weblink Of The Annual Report: 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9dac91ce-e40a-4901-9196-3b90d7593183.pdf) |
| 2026-08-26 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71d37847-0e4d-4e4d-bf1c-7f944e47c85a.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Acquisition](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9424cafd-daa2-4c5f-a6dd-e0dc9e5f4b34.pdf) |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83833b7b-acb9-4a54-b910-4fb06165b6ad.pdf) |
| 2026-08-04 | [Board Meeting Outcome for For Q1 FY 27 Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c859e354-ad52-4874-bb1e-289ba4eaa9bf.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-04 | [Q1 FY 27 Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e29e4714-2578-45d5-b273-15ec1f4f637e.pdf) |
| 2026-05-26 | [Please Find Attached Quarter And Financial Year Ended March 31 2026 Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c19bee0-2d52-44ad-884b-2ea5a9f8709b.pdf) |
| 2026-02-10 | [Q3 And Nine Months FY26 Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff316e1f-1028-4c2c-9fa5-1ef87f54e456.pdf) |
| 2025-11-14 | [Q2 FY26 Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b392093-3acd-4967-b723-db96bd21633f.pdf) |
| 2025-08-06 | [Q1-FY 26 Unaudited Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74e4f78c-8936-454e-8eaf-e6b0c7d3b794.pdf) |
| 2025-05-12 | [Audited Financial Results (Consolidated And Standalone) For The Quarter / Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c3213f4-d2a0-42d3-8f28-4b8df2e9debf.pdf) |
| 2025-05-12 | [Results - Q4 & FY 25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08bba81a-844d-459f-9cef-ed6a33e19388.pdf) |
| 2025-02-06 | [Results - Q3 FY 25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30af4f1b-2311-414b-be5a-1fdd1bd6a736.pdf) |
| 2024-11-11 | [Results - Q2 FY 25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8f1c176-8ff2-44ef-8be7-c3be6c3484a1.pdf) |
| 2024-08-12 | [Results Q 1 FY 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76a56ee0-24d0-4ecf-bfbd-973f9880c9f2.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50e45220-59b1-41b6-b323-1bf7c3718e01.pdf) |
| 2026-05-27 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71855258-33c4-49de-a9ce-2bbfd4a93bc9.pdf) |
| 2026-02-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=864c812f-bdb9-4ed3-b185-3eb8c54bea52.pdf) |
| 2025-11-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa06ebc2-ccb2-4517-b132-573e056b37d5.pdf) |
| 2025-08-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28584864-96e0-424a-9bed-30e2567dafb5.pdf) |
| 2025-05-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=961724a7-2500-4c97-b155-319614b29186.pdf) |
| 2025-02-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67611ed7-e6ed-4fd2-9d1a-887b3ac76828.pdf) |
| 2024-11-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49342495-83ce-40dc-ae69-19b51d52eaec.pdf) |
| 2024-08-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19da10fa-b727-4456-afd6-3d227a398150.pdf) |
| 2024-05-22 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b75fa46c-a25d-42d9-8b31-1625a18c80ea.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 6 May - CARE Q4FY26 report shows no deviation; Baddi timeline extended to March 2027; GST SCN Rs117.94 crore disclosed. | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report 6 May - CARE Q4FY26 report shows no deviation; Baddi timeline extended to March 2027; GST SCN Rs117.94 crore disclosed.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a6355b76-f68e-4b0c-b016-fef264442eb2.pdf) |
| 5h - FY26 secretarial compliance report notes unresolved capital reduction issue for 5,062,872 shares; exchange refused listing alignment. | [Compliances-Reg.24(A)-Annual Secretarial Compliance 5h - FY26 secretarial compliance report notes unresolved capital reduction issue for 5,062,872 shares; exchange refused listing alignment.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b400c779-9c51-4f78-9300-ad7f604800e4.pdf) |
| 23 Feb - Secured ₹825 crore (USD 91m) multi-year CDMO mandate; supplies begin in 4–5 months. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 23 Feb - Secured ₹825 crore (USD 91m) multi-year CDMO mandate; supplies begin in 4–5 months.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a3f8aa0c-4cd5-4c03-9141-8edf1bb366cd.pdf) |
| 23 Feb - Morepen bags ₹825 crore international CDMO contract; supplies start in 4–5 months, execution over 12–15 months. | [Announcement Under Regulation 30 SEBI (LODR)- Bagging Of Order 23 Feb - Morepen bags ₹825 crore international CDMO contract; supplies start in 4–5 months, execution over 12–15 months.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9a8adba3-2fdb-4577-863c-2d02aa5cce0d.pdf) |
| 23 Apr - Morepen Laboratories approved ₹30 crore unsecured term loan from Shinhan Bank on April 23, 2026. | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements 23 Apr - Morepen Laboratories approved ₹30 crore unsecured term loan from Shinhan Bank on April 23, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fe0d1f38-8f81-4524-a129-a92431e4ab17.pdf) |
| 17 Apr - Masulkhana, Himachal Pradesh API facility cleared by USFDA on 17 Apr 2026 with NIL Form 483. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 17 Apr - Masulkhana, Himachal Pradesh API facility cleared by USFDA on 17 Apr 2026 with NIL Form 483.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d8a6bdd5-9b4c-47c1-9d4c-709392ba2feb.pdf) |
| 15 Apr - Newspaper Advertisement regarding Special Window for transfer and dematerialization of physical shares | [Announcement under Regulation 30 (LODR)-Newspaper Publication 15 Apr - Newspaper Advertisement regarding Special Window for transfer and dematerialization of physical shares](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c2ac9249-1c20-4342-b007-09be7eaeee69.pdf) |
| 12 Feb - Executed Rs50 crore unsecured term loan with Woori Bank; 3-year tenure, 1-year moratorium; promoter guarantee; dated Feb 12, 2026. | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements 12 Feb - Executed Rs50 crore unsecured term loan with Woori Bank; 3-year tenure, 1-year moratorium; promoter guarantee; dated Feb 12, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/722d17e4-cef4-4b75-9fa0-eb28a3b650f6.pdf) |
| 11h - Morepen Laboratories approved ₹30 crore unsecured term loan from Shinhan Bank on April 23, 2026. | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements 11h - Morepen Laboratories approved ₹30 crore unsecured term loan from Shinhan Bank on April 23, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/fe0d1f38-8f81-4524-a129-a92431e4ab17.pdf) |
| 11 Mar - Rs99.00 crore Kotak facility fully repaid effective March 2, 2026; no dues, security to be released. | [Closure Of Credit Facility - Kotak Mahindra Bank 11 Mar - Rs99.00 crore Kotak facility fully repaid effective March 2, 2026; no dues, security to be released.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7fdca43b-9fa6-4fb2-bb1b-ac8f5ab813f6.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2020 | [Concall - Sep 2020](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70ad2f70-d83a-4ed4-a799-9c0f50fff869.pdf) |
| Sep 2020 | [Concall - Sep 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/70ad2f70-d83a-4ed4-a799-9c0f50fff869.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fa06ebc2-ccb2-4517-b132-573e056b37d5.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdb7e5c8-9b50-4384-987b-8f4cf500ede3.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cdb7e5c8-9b50-4384-987b-8f4cf500ede3.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6bfb9ace-9cc8-4a6c-89a2-8f83f8963aed.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/326f4699-df53-46a2-b0d5-1360422f11f7.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ad4f77f-92e0-4ce1-9c5b-f5a6fe37ec0e.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a05a632-0505-4765-9912-69d69f020712.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6a05a632-0505-4765-9912-69d69f020712.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2025-05-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=091c81e5-c3d4-4227-ba31-ef8174c9edf7.pdf) |
| 2025-02-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6edf72a9-ffae-4c04-bea0-d399817dd932.pdf) |
| 2024-08-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c0661eb-cf59-46c5-b00a-c83caeb5bcf9.pdf) |
| 2024-05-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22260977-a0bb-4b84-8715-00f8aaf4a29e.pdf) |
| 2024-02-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f16d25ac-c340-497e-9d7c-50b246f11958.pdf) |
| 2023-11-08 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bfb9ace-9cc8-4a6c-89a2-8f83f8963aed.pdf) |
| 2022-02-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b112bef2-451c-401d-980b-137ee8765900.pdf) |
| 2021-11-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ad4f77f-92e0-4ce1-9c5b-f5a6fe37ec0e.pdf) |
| 2021-07-31 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5151e0e4-c573-4a3d-9113-e4993abe0296.pdf) |
| 2021-05-06 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19ef7db0-a5b1-488b-988b-77ee164e4898.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2025-05-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83f8a18f-8af6-4134-94da-09f0210c762f.pdf) |
| 2024-11-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5658d41-3eaa-4e91-8c7a-54e1ae7f609c.pdf) |
| 2024-08-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cae3be8c-2806-4279-bc7f-ed3501796c5e.pdf) |
| 2024-05-22 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c50b08b-d6ce-4d21-8cdc-c587e320ea5e.pdf) |
| 2024-02-01 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3764ce38-effc-477c-ab52-fec5e47369fb.pdf) |
| 2023-11-03 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a18519b-30b5-42ff-a456-fc07e1e5dcc7.pdf) |
| 2022-05-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74a019eb-757d-4b0d-ab8b-2a03e7b4414d.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/845c3c2d-c15d-4cd7-9506-4f21438c7a09.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/85c24ba1-8b67-4acd-91a6-cfa9c86247f7.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1d777111-b433-49b3-9900-ebb9d4440e23.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500288/75361500288.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500288/71217500288.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/500288/66247500288.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/500288/5002880319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/500288/5002880318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:57:05.343Z.